Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health has announced a quarterly dividend of $0.50 per share, approved by its board of directors. The dividend will be payable on November 1, 2021, to shareholders of record by October 22, 2021. This reflects the company's commitment to returning value to its shareholders.
CVS Health Corporation (NYSE: CVS) will host a conference call on November 3, 2021, at 8:00 a.m. (ET) to discuss its third-quarter 2021 financial results. An audio webcast will be available through the CVS Health Investor Relations website, providing access to interested parties. The webcast will be archived for a year. CVS Health is recognized for delivering comprehensive health solutions, with over 300,000 employees, including more than 40,000 physicians and healthcare professionals, enhancing community health access and affordability.
Aetna, a CVS Health company, announced its 2022 Medicare offerings, emphasizing expanded benefits aimed at improving member health and affordability. With nearly 9.8 million Medicare members, Aetna introduced more than 2.9 million beneficiaries to new Medicare Advantage plans, including $0 premium options available to 84% of eligible beneficiaries. The plans now cover 46 states and D.C., with access extended to additional counties, impacting 53.2 million individuals. Aetna also expanded benefits for Dual Eligible Special Needs Plans and designed specialized coverage for Veterans, addressing social determinants of health.
CVS Health (NYSE: CVS) announced the availability of the Pfizer-BioNTech COVID-19 booster shot starting September 24, 2021, following CDC approval. Eligible populations include individuals 65 and older, those 50-64 with specific medical conditions, and those 18-49 at high risk for severe COVID-19. CVS has administered over 34 million COVID-19 vaccines to date and continues to expand its vaccination efforts, preparing to offer additional booster shots as authorized. CVS encourages appointments for efficiency and accessibility.
CVS Health (NYSE: CVS) is hosting a national career event on September 24, 2021, aiming to recruit 25,000 clinical and retail positions. This initiative is in response to an expected increase in flu cases and ongoing COVID-19 vaccination and testing demand. Most roles include full-time and part-time licensed pharmacists, pharmacy technicians, and nurses. CVS has administered over 34 million COVID-19 vaccines and 32 million tests. The hiring process will be entirely virtual, promoting accessibility for applicants. CVS continues to invest in its workforce with competitive pay and benefits.
CVS Health (NYSE: CVS) announced that President and CEO Karen S. Lynch and Executive Vice President Alan Lotvin, M.D., will participate in a fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference on September 14, 2021, at approximately 8:45 am ET. This event highlights CVS Health's commitment to enhancing community health through its extensive services, including its teams of healthcare professionals. For more information, visit www.cvshealth.com.
CVS Health has opened its first MinuteClinic locations in Washington as part of its nationwide expansion strategy. The MinuteClinic offers affordable healthcare for patients aged 18 months and older, providing services such as diagnosis, treatment, and prescriptions for common illnesses. The new locations are integrated with CVS HealthHUB™, enhancing patient experience with a variety of clinical services. Virtual consultations are also available through the E-Clinic. Most major health insurances are accepted, with transparent pricing for cash or credit patients.
CVS Health Corporation has announced the pricing details for its cash tender offer for up to $2,049,919,000 of its 4.300% Senior Notes due 2028. The tender offer, initiated on August 9, 2021, will allow holders to receive a total consideration of $1,162.08 per $1,000 principal amount of notes tendered, including an early tender payment of $30. The early tender date was August 20, 2021, with settlement expected on August 24, 2021.
CVS Health Corporation (CVS) announced on August 23, 2021, the early results of its cash tender offer, increasing the total amount to $2,049,919,000 from an initial $2,000,000,000. The offer includes 4.300% Senior Notes due 2028 and is open to all registered holders. As of the early tender date, $3,353,427,000 of the notes were validly tendered. CVS expects to prorate the accepted notes due to oversubscription. Payments will be made for accepted tenders on August 24, 2021. The offer does not guarantee acceptance of all tendered notes.
CVS Health (NYSE: CVS) emphasizes the importance of vaccinations as the country navigates the COVID-19 pandemic. A survey reveals that 71% of U.S. consumers intend to receive a flu shot, marking a 5% increase from June 2020. CVS Health has administered around 30 million COVID-19 vaccinations and over 20 million flu shots in the past year. Flu shots are available at all CVS Pharmacy and MinuteClinic locations, with convenient scheduling options.
Customers can receive a $5 off $20 shopping pass with any vaccine visit while supplies last, valid through 12/31.